Investor profile
HERAN Partners
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
HERAN Partners is a specialist venture capital investor committed to creating transformative impact within the life sciences and healthcare industry. The firm invests in both hardware and software companies in the HealthTech and MedTech space across Europe, focusing on disruptive technology with the potential for global-scale impact and substantial clinical relevance. HERAN looks for differentiated approaches built on solid IP and know-how — spanning precision medicine, genomics, proteomics, AI-driven diagnostics, and drug discovery — by teams with a down-to-earth attitude and profound industry knowledge. As an active and engaged investor, HERAN provides venture and growth capital alongside mentorship, hands-on operational support, and a strong European network, targeting companies from seed through Series B that can demonstrate feasibility to bring disruptive innovation to market.
Notable quotes
“The next efficiency leap in healthcare will not come from simply generating more data, but from better insights. Technology should support clinicians and researchers — not overload them.”
“Healthtech is not a sprint — it's a marathon. We want to support companies throughout that entire journey: from promising technology to tangible impact for businesses and patients alike.”
“We always look for disruptive technology with the potential to have an impact on a global scale, in combination with substantial clinical relevance.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Hypervision Surgical | Series A | $23m | 2026-04-29 |
| Fluidic Sciences | Seed | — | 2026-04-09 |
| Pharmacelera | Series A | $7m | 2026-02-12 |
| Gynaia | Seed | — | 2025 |
| Nuclivision | Seed | — | 2025 |
| Broken String Biosciences | Series A | — | 2023-08 |
| Aspect Analytics | Seed | — | 2022 |
| Amaron | Seed | — | 2021 |
| icometrix | Seed | — | 2019 |
| Thirona | Seed | — | 2021 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Redalpine | 2 |
| LifeX Ventures | 2 |
| ZEISS Ventures | 2 |
| Illumina Ventures | 1 |
| Mérieux Equity Partners | 1 |
| Heal Capital | 1 |
Fit check
Is HERAN Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit